Give Synagis Via Home Care: A Reply

To the Editor .— I would like to expand on the issues raised by Dr Goldenring in his January 2007 letter to the editor.1 Dr Goldenring suggests that US health care authorities should consider the administration of Synagis (palivizumab) via home care. In my home country of the Netherlands, and similar to clinical practice in the Untied States, at-risk candidates for respiratory syncytial virus (RSV) prevention with Synagis include those with prematurity, …